Cargando…

MON-396 Biochemically Silent Adrenal Mass in a Hypertensive Female

We describe a case of a biochemically silent pheochromocytoma, which raises the question about the appropriate pre-operative approach in cases of biochemically “silent” adrenal tumors. A 37-year-old white female was referred to our endocrinology clinic for evaluation of a large right sided adrenal i...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheynshteyn, Mark, Sinnott, Bridget, Mittal, Pardeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550680/
http://dx.doi.org/10.1210/js.2019-MON-396
_version_ 1783424236309708800
author Sheynshteyn, Mark
Sinnott, Bridget
Mittal, Pardeep
author_facet Sheynshteyn, Mark
Sinnott, Bridget
Mittal, Pardeep
author_sort Sheynshteyn, Mark
collection PubMed
description We describe a case of a biochemically silent pheochromocytoma, which raises the question about the appropriate pre-operative approach in cases of biochemically “silent” adrenal tumors. A 37-year-old white female was referred to our endocrinology clinic for evaluation of a large right sided adrenal incidentaloma. She was symptomatic for episodic severe migratory headaches, dizziness, intermittent orthostasis and anxiety. She was being treated for hypertension with labetalol 200mg twice daily. She denied any family history of pheochromocytomas or adrenal tumors. Her physical examination was unremarkable apart from BP 191/115, with regular heart rate of 93 beats per minute. Her BMI was 19 and she did not exhibit any cushingoid features. She had undergone biochemical testing 17 months prior, which included 24 hour urine fractionated metanephrines and catecholamines, 1mg overnight dexamethasone suppression test and aldosterone level, all of which were unremarkable. Biochemical work-up was again repeated and included fractionated metanephrines <0.20nmol/L (normal <0.50nmol/L), normetanephrines <0.70nmol/L (normal <0.90nmol/L), aldosterone 16ng/dl (normal <21ng/dl), renin activity 3.8ng/ml/hr (0.6-4.3ng/ml/hr), late night salivary cortisol <50ng/dl (normal <100ng/dl), total testosterone 26ng/dl (14-76ng/dl) and DHEA-S 3.1ng/ml (normal <10ng/ml). Results were consistent with a non-functional adrenal tumor. CT imaging was remarkable for 8.0 x 7.5 x 7.0 cm well defined heterogeneous solid and cystic mass involving the right adrenal gland, the central necrotic portion of the mass showed no enhancement, whereas the peripheral solid portion of the mass showed progressive enhancement with HU values of 50, 67 and 75 on unenhanced CT, arterial phase and portal venous phase respectively and no wash out findings. Patient was started on an alpha blocking agent with dramatic improvement in her blood pressure perioperatively. She underwent successful open right sided adrenalectomy. Pathology was remarkable for a pheochromocytoma. Pheochromocytomas are rare neuroendocrine tumors originating from chromaffin tissue, which can be associated with significant morbidity and mortality. It is not uncommon for these tumors to be clinically silent but it is rare for them to be biochemically silent. This case highlights the importance of reviewing the adrenal imaging phenotype and following clinical suspicion and treating perioperatively as a pheochromocytoma, despite a negative biochemical work-up. If untreated perioperatively with adequate alpha blockade, these cases can result in a perioperative hemodynamic instability, adrenergic crisis and potentially death.
format Online
Article
Text
id pubmed-6550680
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65506802019-06-13 MON-396 Biochemically Silent Adrenal Mass in a Hypertensive Female Sheynshteyn, Mark Sinnott, Bridget Mittal, Pardeep J Endocr Soc Adrenal We describe a case of a biochemically silent pheochromocytoma, which raises the question about the appropriate pre-operative approach in cases of biochemically “silent” adrenal tumors. A 37-year-old white female was referred to our endocrinology clinic for evaluation of a large right sided adrenal incidentaloma. She was symptomatic for episodic severe migratory headaches, dizziness, intermittent orthostasis and anxiety. She was being treated for hypertension with labetalol 200mg twice daily. She denied any family history of pheochromocytomas or adrenal tumors. Her physical examination was unremarkable apart from BP 191/115, with regular heart rate of 93 beats per minute. Her BMI was 19 and she did not exhibit any cushingoid features. She had undergone biochemical testing 17 months prior, which included 24 hour urine fractionated metanephrines and catecholamines, 1mg overnight dexamethasone suppression test and aldosterone level, all of which were unremarkable. Biochemical work-up was again repeated and included fractionated metanephrines <0.20nmol/L (normal <0.50nmol/L), normetanephrines <0.70nmol/L (normal <0.90nmol/L), aldosterone 16ng/dl (normal <21ng/dl), renin activity 3.8ng/ml/hr (0.6-4.3ng/ml/hr), late night salivary cortisol <50ng/dl (normal <100ng/dl), total testosterone 26ng/dl (14-76ng/dl) and DHEA-S 3.1ng/ml (normal <10ng/ml). Results were consistent with a non-functional adrenal tumor. CT imaging was remarkable for 8.0 x 7.5 x 7.0 cm well defined heterogeneous solid and cystic mass involving the right adrenal gland, the central necrotic portion of the mass showed no enhancement, whereas the peripheral solid portion of the mass showed progressive enhancement with HU values of 50, 67 and 75 on unenhanced CT, arterial phase and portal venous phase respectively and no wash out findings. Patient was started on an alpha blocking agent with dramatic improvement in her blood pressure perioperatively. She underwent successful open right sided adrenalectomy. Pathology was remarkable for a pheochromocytoma. Pheochromocytomas are rare neuroendocrine tumors originating from chromaffin tissue, which can be associated with significant morbidity and mortality. It is not uncommon for these tumors to be clinically silent but it is rare for them to be biochemically silent. This case highlights the importance of reviewing the adrenal imaging phenotype and following clinical suspicion and treating perioperatively as a pheochromocytoma, despite a negative biochemical work-up. If untreated perioperatively with adequate alpha blockade, these cases can result in a perioperative hemodynamic instability, adrenergic crisis and potentially death. Endocrine Society 2019-04-30 /pmc/articles/PMC6550680/ http://dx.doi.org/10.1210/js.2019-MON-396 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Adrenal
Sheynshteyn, Mark
Sinnott, Bridget
Mittal, Pardeep
MON-396 Biochemically Silent Adrenal Mass in a Hypertensive Female
title MON-396 Biochemically Silent Adrenal Mass in a Hypertensive Female
title_full MON-396 Biochemically Silent Adrenal Mass in a Hypertensive Female
title_fullStr MON-396 Biochemically Silent Adrenal Mass in a Hypertensive Female
title_full_unstemmed MON-396 Biochemically Silent Adrenal Mass in a Hypertensive Female
title_short MON-396 Biochemically Silent Adrenal Mass in a Hypertensive Female
title_sort mon-396 biochemically silent adrenal mass in a hypertensive female
topic Adrenal
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550680/
http://dx.doi.org/10.1210/js.2019-MON-396
work_keys_str_mv AT sheynshteynmark mon396biochemicallysilentadrenalmassinahypertensivefemale
AT sinnottbridget mon396biochemicallysilentadrenalmassinahypertensivefemale
AT mittalpardeep mon396biochemicallysilentadrenalmassinahypertensivefemale